Fleury is a leading provider of diagnostic medicine in Brazil. The company offers comprehensive laboratory testing, advanced imaging procedures, and preventive health solutions. Fleury is synonymous with high-quality medical diagnostics and patient-centric care, serving as a trusted partner in healthcare.
Date confirmed from the company's own financial calendar (MZ platform).
After-hours — after the market close (typically after 5:30 p.m. CET).
Fleury is scheduled to report its next quarterly earnings on 11/05/2026. After-hours — after the market close (typically after 5:30 p.m. CET).
Fleury last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 0.41 BRL.
Across its last 4 earnings reports, Fleury stock moved by ±3.4% on average the following day. The largest reaction was +9.7% on 08/06/2026; 3 of 4 reactions were positive.
Fleury has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.